| Primary |
| Product Used For Unknown Indication |
41.3% |
| Pancreatic Insufficiency |
9.4% |
| Diabetes Mellitus |
6.8% |
| Drug Use For Unknown Indication |
5.1% |
| Hypertension |
4.4% |
| Pancreatitis Chronic |
3.8% |
| Cystic Fibrosis |
3.8% |
| Ill-defined Disorder |
3.7% |
| Malnutrition |
2.6% |
| Prophylaxis |
2.6% |
| Pancreatitis |
2.5% |
| Diarrhoea |
1.9% |
| Pain |
1.7% |
| Diagnostic Procedure |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Pancreatic Carcinoma |
1.6% |
| Vitamin Supplementation |
1.5% |
| Gastritis Atrophic |
1.5% |
| Dyspepsia |
1.2% |
| Medical Diet |
1.2% |
|
| Diarrhoea |
10.8% |
| Weight Decreased |
9.7% |
| Distal Intestinal Obstruction Syndrome |
9.0% |
| Drug Ineffective |
8.6% |
| Vomiting |
8.3% |
| Flatulence |
5.4% |
| Death |
5.0% |
| Abdominal Pain |
4.3% |
| Nausea |
4.0% |
| Rash |
4.0% |
| Unevaluable Event |
4.0% |
| Constipation |
3.2% |
| Pyrexia |
3.2% |
| Urticaria |
3.2% |
| Abdominal Pain Upper |
2.9% |
| Gastric Cancer |
2.9% |
| Malaise |
2.9% |
| Pancreatitis |
2.9% |
| Pancreatitis Acute |
2.9% |
| Pneumonia |
2.9% |
|
| Secondary |
| Diagnostic Procedure |
15.6% |
| Gastritis Atrophic |
15.0% |
| Angle Closure Glaucoma |
11.2% |
| Product Used For Unknown Indication |
10.8% |
| Diarrhoea |
8.1% |
| Pancreatic Carcinoma Recurrent |
6.3% |
| Osteoporosis |
4.0% |
| Pancreatectomy |
3.9% |
| Dry Eye |
3.8% |
| Cataract |
3.7% |
| Enterocolitis Viral |
3.7% |
| Hepatic Function Abnormal |
3.7% |
| Pancreatic Insufficiency |
1.9% |
| Drug Use For Unknown Indication |
1.8% |
| Diabetes Mellitus |
1.3% |
| Hypertension |
1.3% |
| Pancreatitis Chronic |
1.2% |
| Cystic Fibrosis |
1.2% |
| Cervicobrachial Syndrome |
0.7% |
| Malnutrition |
0.7% |
|
| Pyrexia |
45.6% |
| Ascites |
8.4% |
| Drug Ineffective |
5.3% |
| Weight Decreased |
5.3% |
| Distal Intestinal Obstruction Syndrome |
3.2% |
| Flatulence |
3.2% |
| Pancreatitis Acute |
3.2% |
| Vomiting |
3.2% |
| Diarrhoea |
2.5% |
| Off Label Use |
2.5% |
| Cervicobrachial Syndrome |
2.1% |
| Pancreatitis |
2.1% |
| Rash Pruritic |
2.1% |
| Weight Increased |
2.1% |
| Pruritus |
1.8% |
| Steatorrhoea |
1.8% |
| White Blood Cell Count Decreased |
1.8% |
| Gastrointestinal Hypomotility |
1.4% |
| Intentional Drug Misuse |
1.4% |
| Intestinal Mucosal Hypertrophy |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.7% |
| Drug Use For Unknown Indication |
10.9% |
| Cystic Fibrosis |
9.1% |
| Hypertension |
5.7% |
| Pancreatic Carcinoma |
5.6% |
| Pain |
5.6% |
| Crohn's Disease |
3.8% |
| Diabetes Mellitus |
3.1% |
| Nausea |
3.0% |
| Pancreatic Insufficiency |
3.0% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Depression |
2.2% |
| Osteoporosis |
2.2% |
| Diarrhoea |
2.1% |
| Prophylaxis |
2.1% |
| Pancreatic Carcinoma Metastatic |
2.0% |
| Adenocarcinoma Pancreas |
1.8% |
| Rheumatoid Arthritis |
1.7% |
| Dyspepsia |
1.6% |
| Constipation |
1.5% |
|
| Weight Decreased |
14.3% |
| Vomiting |
14.1% |
| Death |
6.4% |
| Pyrexia |
5.8% |
| Renal Failure Acute |
5.0% |
| Thrombocytopenia |
5.0% |
| Pancreatitis |
4.6% |
| Weight Increased |
4.6% |
| Malaise |
4.4% |
| Infective Pulmonary Exacerbation Of Cystic Fibrosis |
4.0% |
| Tremor |
4.0% |
| Pancreatic Carcinoma |
3.4% |
| Pancreatitis Acute |
3.4% |
| Thrombosis |
3.4% |
| Neutropenia |
3.2% |
| Respiratory Failure |
3.2% |
| Pneumonia |
3.0% |
| Diarrhoea |
2.6% |
| Myocardial Infarction |
2.6% |
| Pain In Extremity |
2.6% |
|
